The follow-up study, which will enroll patients who had asymptomatic or symptomatic COVID-19 during pregnancy, will assess patients’ symptoms periodically throughout the four-year period and evaluate their offspring for neurologic symptoms and cardiovascular conditions, according to a Nov. 2 news release.
The research team — led by Torri Metz, MD, associate professor of obstetrics and gynecology at the University of Utah School of Medicine in Salt Lake City — will seek to determine what proportion of pregnant people with COVID-19 are at risk for long-term effects and whether illness severity affects the likelihood of developing long COVID-19.
It’s part of the NIH’s larger project to evaluate long COVID-19, known as the Researching COVID to Enhance Recovery, or RECOVER, Initiative.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
